Physics-based design and simulation of hollow-core anti-resonant fiber plasmonic sensors.

Publication date: May 16, 2026

Next-generation sensing technologies require high-performance sensors that offer ultra-low loss with enhanced sensitivity. To achieve this, we propose a hollow-core anti-resonant fiber (HC-ARF) refractive index (RI) sensor utilizing the surface plasmon resonance (SPR) detection mechanism for superior optical sensing performance. The proposed sensor model features a single ring of uniformly arranged regular cladding tubes, each coated with a thin plasmonic metal layer to facilitate strong coupling between the core and surface plasmon modes. Through rigorous finite-element modeling (FEM) simulations, the fiber structure is carefully optimized and sensing performance is investigated to obtain ultra-low loss and high detection sensitivity via wavelength interrogation. The simulation results show that the proposed HC-ARF sensor achieves losses up to two orders of magnitude lower than conventional solid-core fiber sensors. Notably, the sensor achieves enhanced wavelength sensitivity (WS) of 6500 and 11,500 nm/RIU for analyte RIs of 1. 33 and 1. 43, respectively, effectively spanning the visible to near-infrared spectrum with a broad sensing range from 1. 25 to 1. 44. Moreover, it shows stable performance under tight bending conditions with 10 cm bend radius and +/-4% variations in geometric parameters. The combination of relatively low-loss, wide detection range, and high sensing performance makes this sensor effective for real-time RI monitoring applications such as glucose and sucrose concentration analysis, cancer cell detection, and SARS-CoV-2 identification.

Open Access PDF

Concepts Keywords
Analyte Anti
Glucose Core
Physics Detection
Strong Fiber
High
Hollow
Loss
Low
Plasmonic
Resonant
Sensing
Sensitivity
Sensor
Sensors
Simulation

Semantics

Type Source Name
drug DRUGBANK Dextrose unspecified form
drug DRUGBANK Sucrose
disease MESH cancer
pathway REACTOME Reproduction
disease MESH included
drug DRUGBANK Silicon dioxide
drug DRUGBANK Medical air
disease MESH glass
drug DRUGBANK Gold
drug DRUGBANK Water
drug DRUGBANK Guanosine
drug DRUGBANK Droxidopa
drug DRUGBANK Sulpiride
drug DRUGBANK Aspartame
drug DRUGBANK Isoxaflutole
drug DRUGBANK Silver
drug DRUGBANK Copper
disease MESH Blood cancer
disease MESH Adrenal gland cancer
disease MESH Skin cancer
disease MESH Cervical cancer
disease MESH Breast cancer
pathway KEGG Breast cancer
disease MESH Park
drug DRUGBANK Thyroglobulin
drug DRUGBANK Albendazole
disease MESH glycosuria
drug DRUGBANK Vorinostat
disease MESH severe acute respiratory syndrome

Original Article

(Visited 6 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *